Digital Diabetes Prevention Program Study

NCT06137963 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped This study is no longer feasible due to the increasing number of diabetic patients who are prescribed Ozempic and other GLP-1 agonists.

Conditions

Interventions

Sponsor

Hospital for Special Surgery, New York